Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis

被引：0

作者：

Glajch, Kelly E. ^{[1
]}

Sadri-Vakili, Ghazaleh ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA

来源：

JOURNAL OF HUNTINGTONS DISEASE | 2015年 / 4卷 / 01期

关键词：

Epigenetics; Huntington's disease; DNA methylation; histone modifications; huntingtin; transcription;

D O I：

10.3233/JHD-140134

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Transcriptional dysregulation is an early event and may be an important pathological mechanism in Huntington's disease (HD). However, the exact process that leads to alterations in gene expression in HD is not clear. One potential mechanism underlying transcriptional abnormalities in HD may be epigenetic alterations which regulate gene expression without changing the DNA sequence. Previous work has demonstrated that epigenetic marks, such as DNA methylation and post-translational modifications of histone proteins, are significantly altered in HD cellular and animal models as well as HD patients. Furthermore, studies have shown a therapeutic role for histone deacetylase (HDAC) inhibitors in numerous HD models. Here, we review a range of studies describing epigenetic changes in HD as well as several potential therapeutics that target aberrant epigenetic alterations in HD.

引用

页码：1 / 15

页数：15

共 164 条

[1] THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].

ALBIN, RL ;

YOUNG, AB ;

PENNEY, JB .

TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375

[2] Dopamine D-1 and D-2 receptor gene expression in the striatum in Huntington's disease [J].

Augood, SJ ;

Faull, RLM ;

Emson, PC .

ANNALS OF NEUROLOGY, 1997, 42 (02) :215-221

[3] Disassociation of Histone Deacetylase-3 from Normal Huntingtin Underlies Mutant Huntingtin Neurotoxicity [J].

Bardai, Farah H. ;

Verma, Pragya ;

Smith, Chad ;

Rawat, Varun ;

Wang, Lulu ;

D'Mello, Santosh R. .

JOURNAL OF NEUROSCIENCE, 2013, 33 (29) :11833-11838

[4] Differential contributions of Caenorhabditis elegans histone deacetylases to Huntingtin polyglutamine toxicity [J].

Bates, EA ;

Victor, M ;

Jones, AK ;

Shi, Y ;

Hart, AC .

JOURNAL OF NEUROSCIENCE, 2006, 26 (10) :2830-2838

[5]

Bates G., 2002, HUNTINGTONS DIS, V3rd ed.

[6] Mitochondrial Dysfunction in Neurodegenerative Diseases [J].

Johri, Ashu ;

Beal, M. Flint .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03) :619-630

[7] Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo [J].

Beconi, Maria ;

Aziz, Omar ;

Matthews, Kim ;

Moumne, Lara ;

O'Connell, Catherine ;

Yates, Dawn ;

Clifton, Steven ;

Pett, Hannah ;

Vann, Julie ;

Crowley, Lynsey ;

Haughan, Alan F. ;

Smith, Donna L. ;

Woodman, Ben ;

Bates, Gillian P. ;

Brookfield, Fred ;

Buerli, Roland W. ;

McAllister, George ;

Dominguez, Celia ;

Munoz-Sanjuan, Ignacio ;

Beaumont, Vahri .

PLOS ONE, 2012, 7 (09)

[8] Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner [J].

Benn, Caroline L. ;

Sun, Tingting ;

Sadri-Vakili, Ghazaleh ;

McFarland, Karen N. ;

DiRocco, Derek P. ;

Yohrling, George J. ;

Clark, Timothy W. ;

Bouzou, Berengere ;

Cha, Jang-Ho J. .

JOURNAL OF NEUROSCIENCE, 2008, 28 (42) :10720-10733

[9] Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease [J].

Benn, Caroline L. ;

Butler, Rachel ;

Mariner, Lydia ;

Nixon, Jude ;

Moffitt, Hilary ;

Mielcarek, Michal ;

Woodman, Ben ;

Bates, Gillian P. .

PLOS ONE, 2009, 4 (06)

[10] Oscillatory entrainment of striatal neurons in freely moving rats [J].

Berke, JD ;

Okatan, M ;

Skurski, J ;

Eichenbaum, HB .

NEURON, 2004, 43 (06) :883-896

← 1 2 3 4 5 6 7 8 9 10 →